Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice

Abstract 2-methoxyestradiol (2-ME), an estrogen metabolite generated via catechol-o-methyltransferase (COMT), is multifunctional methoxy-catechol. Here, we report that COMT deficiency leads to glucose intolerance and 2-ME rescues COMT-deficient-associated metabolic defects. Liver COMT protein was su...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Megumi Kanasaki, Swayam Prakash Srivastava, Fan Yang, Ling Xu, Sumiyo Kudoh, Munehiro Kitada, Norikazu Ueki, Hyoh Kim, Jinpeng Li, Satoru Takeda, Keizo Kanasaki, Daisuke Koya
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b583bc08d06d4a32b024507f7393df70
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b583bc08d06d4a32b024507f7393df70
record_format dspace
spelling oai:doaj.org-article:b583bc08d06d4a32b024507f7393df702021-12-02T12:32:57ZDeficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice10.1038/s41598-017-08513-w2045-2322https://doaj.org/article/b583bc08d06d4a32b024507f7393df702017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08513-whttps://doaj.org/toc/2045-2322Abstract 2-methoxyestradiol (2-ME), an estrogen metabolite generated via catechol-o-methyltransferase (COMT), is multifunctional methoxy-catechol. Here, we report that COMT deficiency leads to glucose intolerance and 2-ME rescues COMT-deficient-associated metabolic defects. Liver COMT protein was suppressed in high fat diet (HFD)-fed or in pregnant mice. COMT suppression, by Ro41-0960 or siRNA, in HFD fed mice or in pregnant mice exacerbated glucose intolerance; 2-ME intervention ameliorated these defects. 2-ME effects on glucose tolerance were associated with AMPK phosphorylation in the liver and in islet cells. Metformin restored liver COMT protein levels, and metformin-induced liver AMPK phosphorylation was abolished by COMT inhibition. The amelioration in glucose tolerance by 2-ME was associated with biphasic insulin secretion in an environment-dependent manner. 2-ME-induced insulin secretion was associated with the AMPK phosphorylation, PDX-1 phosphorylation, and MST-1 suppression in MIN-6 cells. Furthermore 2-ME displayed PPARγ agonist-like activity. These results suggest that COMT is an enzyme to maintain glucose homeostasis and 2-ME is a potential endogenous multi-target anti-diabetic candidate.Megumi KanasakiSwayam Prakash SrivastavaFan YangLing XuSumiyo KudohMunehiro KitadaNorikazu UekiHyoh KimJinpeng LiSatoru TakedaKeizo KanasakiDaisuke KoyaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Megumi Kanasaki
Swayam Prakash Srivastava
Fan Yang
Ling Xu
Sumiyo Kudoh
Munehiro Kitada
Norikazu Ueki
Hyoh Kim
Jinpeng Li
Satoru Takeda
Keizo Kanasaki
Daisuke Koya
Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice
description Abstract 2-methoxyestradiol (2-ME), an estrogen metabolite generated via catechol-o-methyltransferase (COMT), is multifunctional methoxy-catechol. Here, we report that COMT deficiency leads to glucose intolerance and 2-ME rescues COMT-deficient-associated metabolic defects. Liver COMT protein was suppressed in high fat diet (HFD)-fed or in pregnant mice. COMT suppression, by Ro41-0960 or siRNA, in HFD fed mice or in pregnant mice exacerbated glucose intolerance; 2-ME intervention ameliorated these defects. 2-ME effects on glucose tolerance were associated with AMPK phosphorylation in the liver and in islet cells. Metformin restored liver COMT protein levels, and metformin-induced liver AMPK phosphorylation was abolished by COMT inhibition. The amelioration in glucose tolerance by 2-ME was associated with biphasic insulin secretion in an environment-dependent manner. 2-ME-induced insulin secretion was associated with the AMPK phosphorylation, PDX-1 phosphorylation, and MST-1 suppression in MIN-6 cells. Furthermore 2-ME displayed PPARγ agonist-like activity. These results suggest that COMT is an enzyme to maintain glucose homeostasis and 2-ME is a potential endogenous multi-target anti-diabetic candidate.
format article
author Megumi Kanasaki
Swayam Prakash Srivastava
Fan Yang
Ling Xu
Sumiyo Kudoh
Munehiro Kitada
Norikazu Ueki
Hyoh Kim
Jinpeng Li
Satoru Takeda
Keizo Kanasaki
Daisuke Koya
author_facet Megumi Kanasaki
Swayam Prakash Srivastava
Fan Yang
Ling Xu
Sumiyo Kudoh
Munehiro Kitada
Norikazu Ueki
Hyoh Kim
Jinpeng Li
Satoru Takeda
Keizo Kanasaki
Daisuke Koya
author_sort Megumi Kanasaki
title Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice
title_short Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice
title_full Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice
title_fullStr Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice
title_full_unstemmed Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice
title_sort deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/b583bc08d06d4a32b024507f7393df70
work_keys_str_mv AT megumikanasaki deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
AT swayamprakashsrivastava deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
AT fanyang deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
AT lingxu deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
AT sumiyokudoh deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
AT munehirokitada deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
AT norikazuueki deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
AT hyohkim deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
AT jinpengli deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
AT satorutakeda deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
AT keizokanasaki deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
AT daisukekoya deficiencyincatecholomethyltransferaseislinkedtoadisruptionofglucosehomeostasisinmice
_version_ 1718393942055059456